Journal article

The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium

Hazel B Nichols, Minouk J Schoemaker, Lauren B Wright, Craig McGowan, Mark N Brook, Kathleen M McClain, Michael E Jones, Hans-Olov Adami, Claudia Agnoli, Laura Baglietto, Leslie Bernstein, Kimberly A Bertrand, William J Blots, Marie-Christine Boutron-Ruault, Lesley Butler, Yu Chen, Michele M Doody, Laure Dossus, A Heather Eliassen, Graham G Giles Show all

Cancer Epidemiology Biomarkers & Prevention | AMER ASSOC CANCER RESEARCH | Published : 2017

Grants

Awarded by Avon Foundation


Awarded by United States National Institutes of Health National Institute of Environmental Health Sciences


Awarded by National Cancer Institute


Awarded by United States National Center for Advancing Translational Sciences


Awarded by Karolinska Institutet Distinguished Professor Award


Awarded by Australia National Health and Medical Research Council


Awarded by Health Research Fund (FIS) (Spain)


Awarded by ISCIII RETIC (Spain)


Awarded by Cancer Research UK (United Kingdom)


Awarded by Medical Research Council (United Kingdom)



Funding Acknowledgements

Support for this research comes, in part, from the Avon Foundation (02-2014-080); Breast Cancer Now; The Institute of Cancer Research, London; the United States National Institutes of Health National Institute of Environmental Health Sciences (Z01 ES044005, P30 ES000260) and National Cancer Institute (UM1 CA176726, UM1 CA186107, UM1 CA182876, UM1 CA182934, UM1 CA164974, R01 CA058420, R01 CA092447, CA077398, CA144034); the United States National Center for Advancing Translational Sciences (KL2-TR001109), the National Program of Cancer Registries of the Centers for Disease Control and Prevention, and the Department of Energy; the Swedish Research Council and Swedish Cancer Foundation; the Japanese Ministry of Health, Labor and Welfare; the Hellenic Health Foundation; Karolinska Institutet Distinguished Professor Award Dnr: 2368/10-221; Cancer Council Victoria and the Australia National Health and Medical Research Council (209057, 396414, 504711); the State of Maryland, the Maryland Cigarette Restitution Fund; and the United Kingdom National Health Service funding to the Royal Marsden/ICR NIHR Biomedical Research Centre. The coordination of the European Prospective Investigation in Cancer is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM; France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); ERC-2009-AdG 232997 and Nordforsk, Nordic Centre of Excellence program on Food, Nutrition and Health (Norway); Health Research Fund (FIS), PI13/00061 to Granada, PI13/01162 to EPIC-Murcia, Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra, ISCIII RETIC (RD06/0020; Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Skane and Vasterbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C570/A16491 and C8221/A19170 to EPIC-Oxford), Medical Research Council (1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford; United Kingdom).